Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
Frontiers in Pharmacology, 2021 Toludesvenlafaxine hydrochloride dihydrate is a novel chemical entity and a potential triple monoamine reuptake inhibitor. This study characterized the in vitro triple reuptake inhibition activity, antidepressant-like activity in animals, and ...
Haibo Zhu +9 more
doaj +1 more source
Long‐acting growth hormone in 2022
Pediatric Investigation, 2023 After the isolation of pituitary growth hormone (GH) in 1957, this form of GH, always in limited supply, was the only drug available for the treatment of GH deficiency.
Margaret Steiner +2 more
doaj +1 more source
Long-Acting Hormonal Contraception [PDF]
Women's Health, 2015 Today, a new category of fertility-regulating agents has been created: long-acting, reversible hormonal contraceptives; they minimize compliance, while maximize effectiveness. They comprise subdermal implants and intrauterine devices. Other long-acting agents exist, such as Depo Provera and Noristerat.
Giuseppe Benagiano +2 more
openaire +3 more sources
Use of Long-Acting Injectables Versus Oral Antipsychotics Among Indigent Populations: A Systematic Review [paper] [PDF]
, 2022 School of Nursing CapstonesIntroduction: Schizophrenia affects approximately 3,810,000 people in the United States and is estimated to cost $155.7 billion.
Ryan, Brooke
core +1 more source
Pharmaceutics, 2022 Dalbavancin (DBV) is a lipoglycopeptide approved for the treatment of Gram-positive infections of the skin and skin-associated structures (ABSSSIs). Currently, its off-label use at different dosages for other infections deserves attention.
Giacomo Stroffolini +12 more
doaj +1 more source
Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease [PDF]
, 2012 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Christopher J Cates +3 more
core +1 more source
Use of Long-Acting Injectables Versus Oral Antipsychotics Among Indigent Populations: A Systematic Review [poster] [PDF]
, 2022 Introduction: Schizophrenia affects approximately 3,810,000 people in the United States and is estimated to cost $155.7 billion. It increases unemployment and poverty, and it is estimated that as much as 25% of the homeless population has schizophrenia ...
Ryan, Brooke
core +1 more source
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease (Review) [PDF]
, 2011 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Christopher J Cates +3 more
core +1 more source
Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease [PDF]
, 2011 Background Long-acting beta2-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However,
David J Evans +12 more
core +1 more source
Journal of Pharmaceutical Analysis, 2013 A highly sensitive ultra-high-performance liquid chromatographicâtandem mass spectrometry (UPLC/MS/MS) method was developed for the quantification of the synthetic peptide drug of exenatide in monkey plasma.
Jin-Feng Zhang +9 more
doaj +1 more source